Osaic Holdings’s vTv Therapeutics VTVT Stock Holding History
Bought
Maintained
Sold
Other funds holding VTVT
SB
SL
BBA
TECP
VCM
VFT
Osaic Holdings's VTVT Position: Q1 2026 in Review
Osaic Holdings reduced its vTv Therapeutics (VTVT) stake by 0.09% in Q1 2026, selling an estimated $36 and leaving 1,119 shares worth $44.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5309.
Osaic Holdings first reported a position in VTVT in Q1 2020 and has held it in 25 quarters since. The position peaked at $44.8K in Q4 2025. 35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.
- Osaic Holdings held 1,119 shares of vTv Therapeutics worth $44.4K as of Q1 2026.
- Osaic Holdings sold 1 vTv Therapeutics share in Q1 2026, an estimated $36.
- vTv Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5309 holding.
- Osaic Holdings first reported a position in vTv Therapeutics in Q1 2020 and has held it in 25 quarters since.
- Osaic Holdings's vTv Therapeutics position peaked at $44.8K in Q4 2025.
- 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.